Vascular Biology |
From the Cardiovascular Division, Department of Medicine (J.A.M., K.G.B., G.G.B, J.M.S., S.E.H., L.W.G., E.R.P., G.S., J.L., I.J.S.), the Department of Chemistry (J.M.R., T.M.), and the Department of Molecular Physiology and Biological Physics (J.L.), University of Virginia Health System, Charlottesville.
Correspondence to Ian J. Sarembock, MD, Box 158, Cardiovascular Division, University of Virginia Health Systems, Charlottesville, VA 22908. E-mail isarembock{at}virginia.edu
AbstractEndothelial activation and leukocyte recruitment are early events in atherosclerosis and the vascular response to injury. Adenosine has anti-inflammatory effects on leukocytes and endothelial cells mediated through its A2A receptor. We tested the hypothesis that A2A activation would reduce inflammation and neointimal formation in a murine carotid ligation model. Before injury, mice were randomized to a 7-day subcutaneous infusion of a specific A2A receptor agonist (ATL-146e, 0.004 µg/kg per minute), vehicle control, ATL-146e plus ZM241385 (a selective A2A antagonist), or ZM241385 alone. Leukocyte recruitment and adhesion molecule expression were assessed at early time points, and the neointimal area was measured at 14 and 28 days after injury. Compared with control mice, ATL-146etreated mice had significantly less neutrophil and macrophage recruitment and vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and P-selectin expression in the first 7 days after injury. Neointimal area was markedly and persistently reduced by 80% at 14 and 28 days, despite termination of ATL infusion at 7 days. ATL-146e+ZM241385treated and ZM241385-treated animals had neointimal areas similar to those of control animals, confirming that the observed effects of ATL-146e were mediated specifically by the A2A receptor. These data demonstrate that novel stimulation of adenosine A2A receptors can inhibit early inflammatory processes that are important in neointimal formation after vascular injury.
Key Words: adenosine restenosis cell adhesion molecules endothelium leukocytes
This article has been cited by other articles:
![]() |
R. W. S. Li, R. Y. K. Man, P. M. Vanhoutte, and G. P. H. Leung Stimulation of ecto-5'-nucleotidase in human umbilical vein endothelial cells by lipopolysaccharide Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1177 - H1181. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, K. Ravid, and B. D. Smith Major Histocompatibility Class II Transactivator Expression in Smooth Muscle Cells from A2b Adenosine Receptor Knock-out Mice: CROSS-TALK BETWEEN THE ADENOSINE AND INTERFERON-{gamma} SIGNALING J. Biol. Chem., May 23, 2008; 283(21): 14213 - 14220. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Yang, M. Koupenova, D. J. McCrann, K. J. Kopeikina, H. M. Kagan, B. M. Schreiber, and K. Ravid The A2b adenosine receptor protects against vascular injury PNAS, January 15, 2008; 105(2): 792 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kaetsu, Y. Yamamoto, S. Sugihara, T. Matsuura, G. Igawa, K. Matsubara, O. Igawa, C. Shigemasa, and I. Hisatome Role of cysteinyl leukotrienes in the proliferation and the migration of murine vascular smooth muscle cells in vivo and in vitro Cardiovasc Res, October 1, 2007; 76(1): 160 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Glover, M. Ruiz, K. Takehana, F. D. Petruzella, J. M. Rieger, T. L. Macdonald, D. D. Watson, J. Linden, and G. A. Beller Cardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3164 - H3171. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Orr, R. Stockton, M. B. Simmers, J. M. Sanders, I. J. Sarembock, B. R. Blackman, and M. A. Schwartz Matrix-specific p21-activated kinase activation regulates vascular permeability in atherogenesis J. Cell Biol., February 26, 2007; 176(5): 719 - 727. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zernecke, K. Bidzhekov, B. Ozuyaman, L. Fraemohs, E. A. Liehn, J. M. Luscher-Firzlaff, B. Luscher, J. Schrader, and C. Weber CD73/Ecto-5'-Nucleotidase Protects Against Vascular Inflammation and Neointima Formation Circulation, May 2, 2006; 113(17): 2120 - 2127. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Toufektsian, Z. Yang, K. M. Prasad, L. Overbergh, S. I. Ramos, C. Mathieu, J. Linden, and B. A. French Stimulation of A2A-adenosine receptors after myocardial infarction suppresses inflammatory activation and attenuates contractile dysfunction in the remote left ventricle Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1410 - H1418. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ralph, A. N. McEvoy, D. Kane, B. Bresnihan, O. FitzGerald, and E. P. Murphy Modulation of Orphan Nuclear Receptor NURR1 Expression by Methotrexate in Human Inflammatory Joint Disease Involves Adenosine A2A Receptor-Mediated Responses J. Immunol., July 1, 2005; 175(1): 555 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Orr, J. M. Sanders, M. Bevard, E. Coleman, I. J. Sarembock, and M. A. Schwartz The subendothelial extracellular matrix modulates NF-{kappa}B activation by flow: a potential role in atherosclerosis J. Cell Biol., April 11, 2005; 169(1): 191 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Reece, V. E. Laubach, C. G. Tribble, T. S. Maxey, P. I. Ellman, P. S. Warren, A. M. Schulman, J. Linden, J. A. Kern, and I. L. Kron Adenosine A2A Receptor Agonist Improves Cardiac Dysfunction From Pulmonary Ischemia-Reperfusion Injury Ann. Thorac. Surg., April 1, 2005; 79(4): 1189 - 1195. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Reiss, M. M. Rahman, E. S. L. Chan, M. C. Montesinos, N. W. Awadallah, and B. N. Cronstein Adenosine A2A receptor occupancy stimulates expression of proteins involved in reverse cholesterol transport and inhibits foam cell formation in macrophages J. Leukoc. Biol., September 1, 2004; 76(3): 727 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Headrick, B. Hack, and K. J. Ashton Acute adenosinergic cardioprotection in ischemic-reperfused hearts Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1797 - H1818. [Abstract] [Full Text] [PDF] |
||||
![]() |
J F Kinsel and M V Sitkovsky Possible targeting of G protein coupled receptors to manipulate inflammation in vivo using synthetic and natural ligands Ann Rheum Dis, November 1, 2003; 62(90002): ii22 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Platts, J. Linden, and B. R. Duling Rapid modification of the glycocalyx caused by ischemia-reperfusion is inhibited by adenosine A2A receptor activation Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2360 - H2367. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |